Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens

Journal of Virological Methods

Volumn 173, Issue 2, 2011, Pages 220-226

  Shan, Songhua ^a,c   Jiang, Yongping ^b   Bu, Zhigao ^b   Ellis, Trevor ^a   Zeng, Xianying ^b   Edwards, John ^a   Tian, Guobin ^b   Li, Yanbing ^b   Ge, Jinying ^b   Chen, Hualan ^b   Fenwick, Stan ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c CSIRO   (Australia)

Author keywords

Avian influenza; Chickens; Codon optimization; DNA vaccine; Electroporation; H6 subtype

Indexed keywords

AVIAN INFLUENZA VACCINE; DNA VACCINE; PLASMID DNA; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA H6N2; CHICKEN; CODON; CODON OPTIMIZATION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; ELECTROPORATION; GENE INSERTION SEQUENCE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SEROCONVERSION; VIRAL HEMAGGLUTININ GENE; VIRUS GENE;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; ELECTROPORATION; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION, SECONDARY; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; TIME FACTORS; VACCINATION; VACCINES, DNA;

AVES; GALLUS GALLUS;

EID: 79954606103     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.02.008     Document Type: Article

References (33)

1. Abdulhaqq S.A., Weiner D.B. DNA vaccines: developing new strategies to enhance immune responses. Immunologic Research 2008, 42:219-232.
2. An L.L., Rodriguez F., Harkins S., Zhang J., Whitton J.L. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine 2000, 18:2132-2141.
3. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 1998, 72:1497-1503.
4. Babiuk S., Tsang C., van Drunen Littel-van den Hurk S., Babiuk L.A., Griebel P.J. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry (Amsterdam, Netherlands) 2007, 70:269-274.
5. Ellis T.M., Leung C.Y., Chow M.K., Bissett L.A., Wong W., Guan Y., Malik Peiris J.S. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol. 2004, 33:405-412.
6. Fattori E., La Monica N., Ciliberto G., Toniatti C. Electro-gene-transfer: a new approach for muscle gene delivery. Somat. Cell Mol. Genet. 2002, 27:75-83.
7. Haas J., Park E.C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 1996, 6:315-324.
8. Ikemura T. Codon usage and tRNA content in unicellular and multicellular organisms. Mol. Biol. Evol. 1985, 2:13-34.
9. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., Li Y., Wang X., Ge J., Bu Z., Chen H. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res. 2007, 75:234-241.
10. Ko H.J., Ko S.Y., Kim Y.J., Lee E.G., Cho S.N., Kang C.Y. Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infect Immun. 2005, 73:5666-5674.
11. Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 1997, 71:3391-3396.
12. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 1987, 196:947-950.
13. Kumar S., Yan J., Muthumani K., Ramanathan M.P., Yoon H., Pavlakis G.N., Felber B.K., Sidhu M., Boyer J.D., Weiner D.B. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol. 2006, 25:383-392.
14. Laddy D.J., Yan J., Kutzler M., Kobasa D., Kobinger G.P., Khan A.S., Greenhouse J., Sardesai N.Y., Draghia-Akli R., Weiner D.B. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS One 2008, 3:e2517.
15. Liu M.A., McClements W., Ulmer J.B., Shiver J., Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine 1997, 15:909-912.
16. Ljungberg K., Kolmskog C., Wahren B., van Amerongen G., Baars M., Osterhaus A., Linde A., Rimmelzwaan G. DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. Vaccine 2002, 20:2045-2052.
17. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., Garcia-Hand D., Abdullah R., Braun R., Montefiori D.C., Rosati M., Felber B.K., Pavlakis G.N., Mathiesen I., Israel Z.R., Eldridge J.H., Egan M.A. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J. Virol. 2007, 81:5257-5269.
18. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hinshaw V.S., Swain W.F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 1998, 72:1491-1496.
19. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 1993, 12:777-783.
20. Muthumani K., Lankaraman K.M., Laddy D.J., Sundaram S.G., Chung C.W., Sako E., Wu L., Khan A., Sardesai N., Kim J.J., Vijayachari P., Weiner D.B. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008, 26:5128-5134.
21. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 1996, 70:6119-6125.
22. Sambrook J., Russell D.W. pp. 1.31-31.42 and 31.59-31.61. Molecular Cloning: A laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York. Third ed.
23. Shan, S.H., 2010. Development and Evaluation of DNA Vaccines in Chickens Against a Wild Bird H6N2 Avian Influenza Virus from Western Australia. PhD Thesis, Murdoch University, Australia.
24. Shan S.H., Ellis T., Edwards J., Fenwick S., O'Dea M., Parkinson J. Biological and genetic characterization of a low-pathogenicity avian influenza H6N2 virus originating from a healthy Eurasian coot. Arch Virol. 2010, 155(3):403-409.
25. Suarez D.L., Schultz-Cherry S. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis. 2000, 44:861-868.
26. Tollefsen S., Vordermeier M., Olsen I., Storset A.K., Reitan L.J., Clifford D., Lowrie D.B., Wiker H.G., Huygen K., Hewinson G., Mathiesen I., Tjelle T.E. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand. J. Immunol. 2003, 57:229-238.
27. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 1994, 12:1541-1544.
28. Wang S., Taaffe J., Parker C., Solorzano A., Cao H., Garcia-Sastre A., Lu S. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J. Virol. 2006, 80:11628-11637.
29. Wang S., Zhang C., Zhang L., Li J., Huang Z., Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008, 26:2100-2110.
30. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., Leung L., Otten G.R., Thudium K., Selby M.J., Ulmer J.B. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 2000, 164:4635-4640.
31. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
32. Wood J.M., Kawaoka Y., Newberry L.A., Bordwell E., Webster R.G. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis. 1985, 29:867-872.
33. Zucchelli S., Capone S., Fattori E., Folgori A., Di Marco A., Casimiro D., Simon A.J., Laufer R., La Monica N., Cortese R., Nicosia A. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J. Virol. 2000, 74:11598-11607.